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Depleted uranium (DU) is a dense heavy metal usedprimarily in militaryapplications. Although
the health effects ofoccupational uranium exposure are well known, limited data enxst rding
the long-term health effects ofinternaized DU in humans. We established an in viuro cellular
model tostudyDU exposure. Microdosimetricassessment, determined usingaMonteCarlocom-
putersimulation basedonmeasuredintracelular andetacelular u mlevels, showedthatfew
(0.0014%) cell nuldei were hit by alph partidles. We report theability ofDU-uranyl chloride to
tansformimmortalizedhumanosteoblasticcells (HOS) tothetumoriWnicphenotype. DU-uranyl
chloride-transformants are characterized by anchorage-independent growth, tumor formation in
nude mice, expression ofhigh levels ofthe k-rasoncogene, reduced production ofthe Rb tumor-
suppressor protein, and elevated levels ofsister chromatid nges percell. DU-uranyl chloride
treatment resultedina9.6 (±2.8)-foldincrease intrnsformationfrequencycomparedtountreated
cells. Incomparson, nickelsulfate resulted ina7.1 (± 2.1)-fold increase intransformationfrequen-
cy. This is the first report showingthat a DU compound causedhuman cell transormation to the
neoplasticphenotype. Although addtona studies areneededto determineifprotracted DUexpo-
sure produces tumors in vimo, the implication from these in vilro results is that the riskofcancer
inductionfrominternalize DUexposuremaybecomparabletootherbiologicallyreactiveandcar-
cinogenic heavy-metal compounds (e.g., nickel). Key words alpha radiation, depleted uranium,
osteoblast, transformation. EnvironHelthPrpect106:465471 (1998). [Online6July1998]
http://ehpnetl.niehs.nih.gov/docs/1998/106p465-471milkrlabaract.btnl
Several U.S. military personnel participat-
ing in Operation Desert Storm were
wounded in friendly fire accidents and have
retained large fragments (approximately
2-20 mm) of depleted uranium (DU) in
their bodies. DU, used in military muni-
tions in the United States, was shown to be
an effective material in kinetic energy pene-
trators in the 1991 Persian Gulf War.
Chemically similar to natural uranium (1),
DU is a low specific-activity heavy metal,
with a density approximately 1.7 times that
oflead (19 g/cm3 versus 11.35 g/cm3). DU
differs from natural uranium in that it has
been depleted of235U and 234U. As a result,
the specific activity of DU is significantly
lower than that of natural uranium (0.4
pCi/g versus 0.7 pCi/g, respectively) (2).
Assessment ofthe carcinogenic risks from
DU is complicated by the dual toxicity of
uranium (i.e., chemical as well as radiologi-
cal). Epidemiological studies have linked ura-
nium mining and milling to human carcino-
genesis (1), but there are no published stud-
ies to permit an accurate assessment ofrisks
for carcinogenesis from DU. The radiologi-
cal health risks (external exposure) to person-
nel handling DU munitions were evaluated
and determined to be within allowed occu-
pational exposure limits (1,2); the health
risks from internalized DU, however, are
more difficult to estimate due to the physical
and chemical properties of the internalized
DU (3). The chemical toxicity of acute,
short-term exposures to uranium, primarily
manifested as renal, pulmonary, and devel-
opmental toxicity, has clearly been demon-
strated in animals and humans (4). In con-
trast, the long-term health risks associated
with internal chronic exposure are not as
dearlydefined (1). In viewofcarcinogenesis
risk estimates and medical management
questions relevant to current and possible
future incidents of DU internalization, an
examination of molecular and cellular
effects, induding the potential transforming
ability ofDU, are necessary to understand-
ing the potential carcinogenic effects ofDU.
The use ofcell culture models to investigate
potential or known carcinogens can provide
important insights into the cellular and
molecular mechanisms ofcarcinogenesis.
In spite ofepidemiological studies that
suggest that uranium is a carcinogen (1),
there is no evidence that uranium ofanytype
(depleted, naturally occurring, or enriched)
can transform human cells to the tumori-
genic phenotype (1). Furthermore, the in
vitro transformation assay has not previously
been used to study the transforming ability
ofany uranium compounds (depleted, natu-
rally occurring, or enriched uranium). This
assay has been widely used in conjunction
with metal salts to assess the potential
carcinogenicity of metal compounds (e.g.,
nickel, chromium, lead) (5-) and therefore
we chose to use this assay to assess the poten-
tial carcinogenicity of DU. Investigations
using metal salts have also been able todarify
the contradictions observed in some animal
and human carcinogenicity studies (8). The
HOS TE85 cell line, an immortalized, non-
tumorigenic osteoblastlike cell line, has been
successftully used to demonstrate the transfor-
mation ofnontumorigenic human cells to the
tumorigenic phenotype by metals (7,8) and
chemical (9) carcinogens. We chose the DU
compound DU-U02C12, which readilyforms
the U02j cation in solution, as the depleted
uranium metal salt to be tested. We used
nickel sulfate and lead acetate, which have
previously been shown to transform cells in
vitro, forcomparison.
Our data demonstrate for the first time
that a DU compound can transform human
cells to the tumorigenic phenotype, similar to
results observed with some nickel compounds
(6-8). Isolated DU transformants form
anchorage-independent colonies, produce
tumors when injected into athymic mice,
express the k-rasoncogene, andhave an altered
phosphorylation of the Rb tumor-suppressor
protein. Based on these in vitroresults, the car-
cinogenicpotentialofinternalized DU remains
a concern and warrants additional studies with
experimental animals.
Materials and Methods
Celllines andculture. Human osteosarcoma
cell lines HOS (TE85, clone F-5) were
obtained from the American Type Culture
Collection (Rockville, MD). Cell cultures
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were propagated in Dulbecco's modified
Eagle medium (D-MEM) supplemented
with 2 mM glutamine, 10% heat-inactivat-
ed fetal calf serum (Gibco Laboratories,
Grand Island, NY), 100 U/ml penicillin,
and 100 pg/ml streptomycin (Sigma, St.
Louis, MO). Cells were tested for mycoplas-
ma byMycoTect Kit (Sigma), and only cells
negative formycoplasmawere used.
Transformation andcellgrowth studies.
DU-U02C12 was initially dissolved in ster-
ile water (freely soluble in water). Based on
previous unpublished work with uranyl
compounds which demonstrated that
micromolar concentrations are relatively
nontoxic to cultured cells, we chose a con-
centration of 10 pM for transformation
and cell growth studies. Metal salts were
added to sterile water and then filtered to
prepare concentrated stock solutions that
were used throughout these studies.
Dilutions from concentrated stock solu-
tions were dissolved into complete medium
immediately before exposure. Briefly, 1 x
106 cells were treated with DU-U02C12
(10-250 pM), NiSO4 (10 pM), or lead
acetate (10 pM) for 24 hr in complete
medium. After treatment, cells were rinsed,
trypsinized, counted, and seeded in 100-
mm tissue culture dishes at a density calcu-
lated to yield about 125-225 surviving cells
per dish. Approximately 150 replicate dish-
es were seeded for each treatment group.
The cultures were incubated for 5 weeks
withweeklychanges ofnutrient medium.
For quantitative transformation assess-
ment, at the end of the incubation period,
cells were fixed, stained, and examined for
the appearance oftransformed foci (10). We
assayed transformed foci using the criteria
developed by Reznikoff et al. (1J) and the
IARC/NCI/EPA Working Group (11). The
working group report indicated that because
of the continuum of focus morphology,
some foci can be intermediate (I/II, II/III) in
character, and these foci should be scored
conservatively and assigned to the category
oflower aggressive behavior. With the HOS
cells it was easy to distinguish between a
type I and a type II foci, but somewhat diffi-
cult to differentiate between type II and type
III foci. Therefore, in our experiments, only
type II and type Il/type III foci were scored
as transformants. In Table 1, number of
dishes with foci equals number of foci of
type II plus type III. Details ofthe transfor-
mation frequency calculations and the stan-
dard error were described elsewhere (12) but
are outlined below. Transformed foci are
not contact inhibited and may be dislodged
during refeeding forming satellite colonies.
To avoid this source oferrors, the average
number oftransformed foci per dish, X, was
computed from theproportion ofdishes free
oftransformed colonies,fii.e., X = -Inf.To
determine the transformation frequency, the
following formulawas used:
Transformation frequency=
X/number ofsurviving cells per dish
This calculation has been widely used in
radiation-induced neoplastic transformation
studies to quantitatively compare transfor-
mation frequencies. The transformation
data are presented from three independent
experiments unless otherwise noted.
We determined cell survival fraction
(SF) using the conventional clonogenic
assay (9). Cytotoxicity and survival assays
were conducted in parallel with each trans-
formation assay as described (9). Several
transformed foci were picked by cloning
cylinders and expanded by mass culture to
establish transformed clonal lines. The
transformation dose-response curve was
determined as indicated above, except that
increasing concentrations of DU-UO2C12
were used. We selected the optimal dose
level for transformation following a prelim-
inary toxicity test based upon colony-form-
ing efficiency. The high dose selected
resulted in >90% toxicity, and the lowdose
selected resulted in minimal toxicity. Three
intermediate doses were also selected.
To determine saturation densities, cells
were plated at 1 x 105 cells per 100-mm
diameter plate in complete growth medium
and monitored for growth as previously
described (9). For the soft-agar clonability
assay, cellswereplated atadensityof2x 103
cells per well in a six-well plate sandwiched
by 1-ml bottom agar (0.6%) and 1-mi top
agar (0.3%). Cells were fedweeklybyadding
a new layer of top agar. Colonies >0.5-mm
diameter were scored using a microscope
after2weeks. Theplatingefficiencyvalue for
each clone represents the mean number of
colonies scored from three wells. For both
saturation density determination and plating
efficiency in soft agar, data represent three
independent experiments.
Tumorigenkiiy assay. Experiments were
performed with 4- to 5-week-old female
athymic mice (Division ofCancerTreatment,
NCI Animal Program, Frederick Cancer
Research Facility). Forthis assay, 5 x 106 or 1
x 106 cells in a 0.2-mi sterile suspension were
injected subcutaneously in the right scapula.
Animals were then observed for tumor
growth at the sites ofinjection. The appear-
ance of tumor growth was monitored daily
for 180days. Tumor areawas measuredusing
a caliper measurement of two perpendicular
diameters. When tumors were >100 mm2,
theanimalwaseuthanized.
Sister chromatid analysis. The yield of
sister chromatid exchange (SCE ) per cell
in control and DU-UO22+ exposed cells
following a 24-hr exposure was assessed in
100 second mitotic metaphase spreads (48-
hr culture) using the conventional fluores-
cence-plus-Giemsa harlequin staining pro-
tocol (13). The SCE yield in selected trans-
formed clones wassimilarly determined.
Microdosimetry. The term "specific
energy" is used rather than "dose" because
dose refers to macroscopic averages, whereas
specific energy is a microdosimetric equiva-
lent (i.e., dose to a single cell). We applied
microdosimetric methods using Monte
Carlo computer simulations (14). The code
Table 1. Morphological transformation ofhuman osteoblastlike cells by depleted uranium-uranyl chloride:
comparison to nickel sulfate and lead acetate
No. dishes
withtype 11 No. of Transformation
Concentraton Surviving Survivors/ No. of ortype Illl dishes frequencyper
Metal (pM) fraction dish dishes foci withoutfoci x survivor5x10'4
Experiment 1
None 0 1.0 201 155 13 142 0.084 4.2± 1.1
DU-uranyl chloride 10 0.95 122 165 64 101 0.491 40.2± 5.0
Nickelsulfate 10 0.97 116 150 40 110 0.312 26.9± 3.4
Lead acetate 10 0.99 119 150 31 119 0.237 19.9±2.3
Experiment2
None 0 0.99 180 141 12 129 0.088 4.9± 1.1
DU-uranyl chloride 10 0.96 101 110 40 70 0.448 44.4±5.1
Nickel sulate 10 0.97 110 122 35 87 0.337 30.7 ±3.7
Lead acetate 10 0.97 107 127 25 102 0.219 20.5 ±2.9
Experiment3
None 0 0.99 149 140 9 131 0.066 4.24± 1.0
DU-uranyl chloride 10 0.96 115 120 47 73 0.490 42.6± 5.2
Nickel sulfate 10 0.98 115 120 32 88 0.320 27.5±2.6
Lead acetate 10 0.96 114 120 26 94 0.251 22.3±2.7
'The transformation data illustrated are from three independent experiments involving approximately 400 plates/metal. Transformed foci
were assayed according to the criteria of Reznikoff et al. (10) with type 11 and type Ill foci being scored as transformants. Therefore, the
'dishes with foci' values shown include only those colonies that were morphologically consistent with either type 11 or type 11i foci as
described by Reznikoff et al. The average number oftransformed foci per dish was computed from the proportion of dishes free of trans-
formed colonies, f, byX = -In f. Transformation frequency = Xinumber ofsurviving cells per dish (12).
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was modified to include the following para-
meters in the calculations: cell location and
size, distribution of uranium (intracellular
and extracellular), specific activity, alpha
particle energies, media volume, and molar
concentration ofuranyl chloride. We calcu-
lated the trajectory of each alpha particle
usingvector analysis to determinewhether it
would hit a nucleus. For those that scored a
hit, the amount ofenergy transferred to the
nucleus was calculated by determining the
residual energy retained bythe alpha particle
as it penetrated the nucleus and integrating
the fractional energy loss under the Bragg
curve from the entrypoint to the exitpoint.
Kineticphosphorescenceanalysisofura-
nium. Kinetic phosphorimetry measure-
ments were performed using a kinetic
phosphorescence analyzer (KPA) (15). To
determine the amount of uranium per cell
following a 24-hr treatment with 10 p1M
DU-UO22+, cells were treated and then
rinsed in phosphate-buffered saline. Using
previously described procedures, cells were
lysed and fractionated into subcellular frac-
tions. Lysates were analyzed for uranium
content as described (15).
Northern blotanalysis andDNAprobes.
Cytoplasmic RNA was extracted from expo-
nentially growing cells and separated byelec-
trophoresis in 1% agarose-formaldehyde gels.
RNA preparation and blotting onto nytran
filters, hybridization with radiolabeled DNA
probes, and autoradiography were as previ-
ously described (9). The ras probe, a Sac I
2.9 kb fragment ofthe human k-ras gene,
was obtained from Oncor (Gaithersburg,
MD). Weprepared 32P-labeled DNAprobes
using a random primed DNA labeling kit
(BoehringerMannheim, Germany).
Metabolic labeling andimmunoprecipi-
tation ofpRb. Exponentially growing cells [1
X 106 perT75-cm2 flask (Costar)] were radi-
olabeled with 32P-orthophosphate (250 pCi)
for 24 hr and lysed in buffer (1% Triton X-
100, 0.05 M Tris-HCI, pH 8.0, 5 mM
MgCI2 and 0.1 M NaCI). Lysates were incu-
bated with polyclonal anti-pRb antibody-
agarose conjugates (Oncogene Science, NY)
for 2 hr at40C. Processing ofimmunoprecip-
itates was as previously described (9). The
proteins were resolved on 7.5% polyacry-
lamidegels andanalyzedbyautoradiography.
Results
Characterization ofmodelsystem: cytotoxic-
ity, SCE induction, and microdosimetry.
We initially assessed the effect of DU-
UO2CL2 exposure on cell growth and sur-
vival, cytogenetic damage, and micro-
dosimetry to characterize our cell model
system. No effect on cell survival (surviving
fraction, SF, 0.96 ± 0.04) was observed
using the standard colony formation assay
(9) following a 24-hr exposure to DU-
UO22+ (10 jiM). Growth rate analysis by
cell enumeration and thymidine incorpora-
tion into DNA (9) similarly revealed that
the DU-UO22+ treatment did not affect cell
growth during the 24-hr exposure
(inhibitory concentration, IC50, 45 PM).
Therefore, to preclude excessive cell killing
due to heavy metal toxicity, the nontoxic,
noncytostatic concentration chosen for the
transformation experiment was 10 pM (24-
hr exposure). The colony formation assay
was also used to assess the cytotoxicity of
NiSO4 and lead acetate. Similarly, nontoxic
52
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concentrations of NiSO4 and lead acetate
were chosen (20 pM, SF = 0.94; 20 pM, SF
= 0.095, respectively).
Cytogenetic analysis ofthe acute effect
of the 24-hr exposure to 10 pM DU-
UO 2+ was assessed in the in vitro HOS
model system using the SCE assay. As seen
in Figure IA, this acute DU exposure
caused an approximately twofold increase
in SCE induction (untreated: 8.3 SCE/cell;
DU-UO22+: 17.9 SCE/cell). In compari-
son, lead acetate treatment did not result in
a significant increase in SCEs, while nickel
did induce a small but significant increase
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Figure 1. Characterization of an in vitro HOS cellular model to access DU-UO22+ exposure. The effect of
DU-U022+ exposure (24 hr, 10 pM) on sister chromatid exchange (SCE) induction and a microdosimetric
assessment of the fraction of cell nuclei exposed to DU-induced alpha particles was determined. (A)
Frequency distribution ofSCEformation, measured as described in Materials and Methods. (B) Frequency
distribution of nuclei hit by an alpha particle; microdosimetric assessment was determined using a Monte
Carlo computer simulation based on measured levels of intracellular and extracellular uranium as
described in the methods. F(hit) = 1.4 x 103%.
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in SCEs (lead acetate, 20 pM: 8.9
SCE/cell; NiSO4, 20gM: 11.4 SCE/cell).
Using a standard uranium analysis tech-
nique, KPA (15), the amount of uranium
per cell following a24-hr treatmentwith 10
pM DU-UO22+ was determined to be 1.8
(± 0.15) x 10-6 ng/cell with the average
intercellular concentration being 2gM.
To examine the stochastic fluctuations
ofalpha partide hits and energy deposition
in the cell nudei, microdosimetric methods
using Monte Carlo computer simulations
were applied (Figure 1B). The computer
code, designed by Humm (14) to predict
cell inactivation by internal alpha emitters,
was modified to correspond to the experi-
mental conditions as described in Materials
and Methods. The trajectory ofeach alpha
partide was calculated using vector analysis
to determinewhether itwould hit anudeus.
The energy transferred to the nucleus was
calculated by determining the residual ener-
gy retained by the alpha partide as it pene-
trated the nucleus. The calculations deter-
mined thatonly0.0014% ofthe nudei were
hit and that the mean specific energy
received by those cells was approximately 17
cGy. The results, plotted as a frequency dis-
tribution, areshown in Figure 1B.
Transformation ofHOS cells by DU-
UO/2: comparison to NiSO4 and lead
acetate. To assess for morphological cell
transformation, the standard focus forma-
tion assay described by Reznikoffet al. (10)
and Hill et al. (12) was used. After exposure
to DU-UO22+, a morphological change in
HOS cells was observed (Fig. 2). HOS cells
exhibit a flatepithelial-like morphology and
appear to grow in amonolayer (Fig. 2A). In
contrast, after treatment with DU-UO22+
andweekly changes ofnutrient medium for
5 weeks, diffuse type II foci appeared (Fig.
2B). The morphology of the focus is dis-
tinctly different from the surrounding cells
(Fig. 2B), although the focus does not
exhibit the "piled up" appearance seen in
transformed C3HlOT112 cells (10). Table 1
shows measured values for the transforma-
tion frequencies (normalized per surviving
cell) for HOS cells treated with DU-UO22+
(10 pIM). The transforming abilities of
NiSO4 and lead acetate have been shown
previously (8,16) but are repeated here to
allow for a quantitative comparison to the
DU compound. The data demonstrate that
treatment with DU-UO22+ resulted in a
transformation frequency of 40.2 x 10-4,
which is a 9.6 (± 2.8)-fold increase in trans-
formation compared to untreated HOS
cells. In comparison, the transformation fre-
quencies induced by NiSO4 and lead
acetate treatment resulted in a 7.1 (± 2.1)-
and 5.0 (± 1.6)-fold increase in transforma-
tionfrequencycompared to untreated cells.
Several foci were picked by cloning
cylinders and expanded by mass culture to
establish transformed clonal lines. Four
DU-transformed clones (designated as
DUl, DU2, DU3, and DU4) were select-
ed for tumorigenic and growth analysis; a
NiSO4- and a lead acetate-transformed
clone were also selected for similar analyses.
Aspontaneous focus arising from untreated
HOS cells was also selected andexpanded.
Biologicalcharacterization ofthe trans-
formedphenotype. Alteration in growth
control is critical to neoplastic transforma-
tion, and therefore the metal-transformed
clones were further characterized by quan-
titative differences in growth properties
associated with the neoplastic phenotype
(e.g, saturation density and soft colony-
forming efficiency). Additionally, to deter-
mine if cells transformed in vitro were
capable of producing tumors in immuno-
suppressed mice, the nude mouse assay was
used to test the tumorigenicity of DU-
transformed cells (9,10). From Table 2 it
can be seen that the saturation densities of
DU-transformed cells were three to four
times higher than that ofthe parental HOS
cells. Data obtained for NiSO4- and lead
acetate-transformed cells were similar to
that for DU. A comparison ofthe transfor-
mants' ability to grow in soft agar reveals
that the DU transformants generated
colonies within 1 week, with colony-form-
ing efficiencies of32-51%; the plating effi-
ciencies were somewhat lower for NiSO4-
or lead acetate-transformed cells. Parental
HOS cells did not form colonies in soft
agar (Table 2). We have previously shown
that MNNG and EJ-ras transformants
formed soft agar colonies whose size and
frequency were comparable to those
observedwith these DU transformants (9).
Inoculation ofathymic nude mice with
DU transformants resulted in the develop-
ment ofanimal tumors within 4 weeks. All
of the DU transformed cell lines analyzed
for tumorigenicity appeared to be highly
tumorigenic because as few as 1 million
DU-transformed cells developed progres-
sively growing tumors within 4 weeks.
Similarly, nude mice inoculated with
NiSO4 or lead acetate transformants also
formed tumors (Table 2). In contrast,
parental HOS cells injected into nude mice
did not form any tumors during a period
of 6 months after cell inoculation.
Histological analysis indicates that the
tumors formed by DU-transformed cells
resemble a carcinoma characterized by an
undifferentiated, sheetlike growth. Tumors
were reestablished in tissue culture and
confirmed as human; their resemblance to
Figure 2. Morphology of HOS cells and focus formation after DU-UO22+ exposure. (A) Morphology of control HOS cells; phase contrast micrograph, (x40). (B)
Focus formation in HOS cell;the edge of a focus oftransformed cells is seen against a background of parental HOS cellswith normal morphology (x40).
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Table 2. Biological properties of human osteoblastlike cells transformed by depleted uranium-uranyl chlo-
ride, nickel sulfate, or lead acetate
Saturation Plating Nude mice
density efficiency in with tumors SCE/cell
Metal/clone designation (1 x 105 cells)a soft agar (%)a 5 x 106 cells 1 x 106 cells (mean ± SE)
None/control 2.6 0 0/82 0/20 8.50 ± 0.06
DU-U02C12/DU-1 7.9 51 8/19 6/12 18.53 ± 1.84
DU-UO2C12/DU-2 6.7 32 3/6 2/6 20.11 2.02
DU-U02C12/DU-3 8.2 47 4/6 2/6 21.01 ± 2.12
DU-UO2CIyDU-4 7.8 44 3/6 3/6 18.23 ± 1.88
NiSO4/nickel-1 7.2 29 4/12 2/6 12.29 1.19
PbAc2/lead-1 6.5 19 1/10 ND 11.27 ± 1.02
Abbreviations: SCE, sister chromatid exchange; ND, notdetermined.
aData represent three independent and identical experiments.
bTumor latency was approximately 4weeks.
the cells oforigin was determined by kary-
ological analysis (data not shown).
In contrast to the data presented in
Figure lA which demonstrate "acute" SCE
elevation by DU, "persistent" cytogenetic
changes, manifested as effects on the levels
ofSCEs per cell, were measured in the four
transformed clones selected. Cytogenetic
analysis of the DU-uranyl chloride-trans-
formed clones revealed that all ofthe clones
had a 2.14 (± 0.22)- to 3.47 (± 0.31)-fold
higher level of SCE per cell compared to
parental HOS cells (Table 2). The untreat-
ed, spontaneous HOS transformants did
not exhibit a significant increase in SCE
induction [1.07 (± 0.22)-fold increase]
compared to parental HOS cells.
ras andpRb analysis in DU transfor-
mants. Neoplastic cell transformation is
hypothesized to result from a multistep
process involving activation of oncogenes
and inactivation oftumor-suppressor genes
(17). Both metal- and radiation-induced
neoplastic transformation have been shown
to be associated with genetic alterations in
specific oncogenes and tumor-suppressor
proteins, such as ras and pRb (6,9).
Therefore, possible molecular changes in ras
and pRb associated with DU-induced
transformation were studied using the four
DU-transformed cell lines. Northern blot
analysis, shown in Figure 3A, revealed high
levels of ras mRNA in each ofthe four DU
clones tested. In contrast, the ras mRNA
levels were undetectable in parental HOS.
The amount ofactin mRNA was similar in
all clones tested (not shown). Heavy-
metal-induced transformation (e.g., nickel)
has been shown to cause a loss ofphospho-
rylation of the retinoblastoma protein. We
therefore used anti-pRbl monoclonal anti-
bodies to compare the phosphorylation of
the pRb of the different DU-transformed
cell lines to the parental cells by assessing
the quantity ofradioactive phosphate incor-
porated into the Rb protein. Each of the
DU clones examined exhibited significantly
lower amounts of 32p incorporated into
pRb relative to the parental HOS cells (Fig.
3B). The lack of phosphorylation of pRb
could be a result ofless protein available to
phosphorylate, abnormalities of the cyclin-
associated kinase systems responsible for
phosphorylation ofpRb, a mutation in the
Rbgene, or a combination ofthese possibil-
ities. Previous observations with nickel-
transformed HOS cells demonstrated a
mutation was induced in these transfor-
mants that affected the ability of the Rb
protein to be phosphorylated and function
normally (6).
Dose response: morphological transfor-
mation by UO2CI7 To further evaluate the
ability of DU-uranyl chloride to morpho-
logically transform cells, increasing concen-
trations of DU were tested for their trans-
forming ability. The results in Table 3
show that there is a DU concentration-
dependent increase in transformation fre-
quency. A transformed clone was selected
from each concentration tested and
expanded to mass culture. An examination
of the selected transformants' ability to
grow in soft agar reveals that the DU trans-
formants generated large colonies (>0.5
mm) within 1 week with colony-forming
efficiencies ranging from 33% to 53%.
Inoculation of athymic nude mice with
these DU transformants resulted in the
development oftumors within 4 weeks.
Figure 3. Analysis of K-rasexpression and Rb pro-
tein production in parental HOS and DU-U02C12-
transformed clones. (A) ras Oncogene expres-
sion; Northern blot analysis of cytoplasmic RNA
(20 pg) from DU-1, DU-2, DU-3, DU-4, and HOS.
Hybridization was with a 32P-labeled K-ras probe
(ras transcripts were undetectable in HOS cells).
Hybridization with 32P-labeled actin was used to
indicate that the relative amounts of RNA loaded
into each lane were the same (data not shown).
(B) Rb protein level; immunoprecipitation analysis
of Rb protein from DU-1, DU-2, DU-3, DU-4, and
HOS. Anti-pRbl was used to capture cellular Rb
protein containing 32p.
Discussion
Our studies demonstrate for the first time
that the malignant transformation ofimmor-
talized human cells can be achieved byexpo-
sure to the depleted uranium compound
U02C12. These transformants showed mor-
phological changes and anchorage-indepen-
dent growth in soft agar, induced tumors
when transplanted into nude mice, and
exhibited alterations in ras oncogene expres-
sion and pRb phosphorylation. Based on
equivalent concentrations and metal toxici-
ties, the magnitude of this DU-UO22+
transformation is comparable to that seen
here for NiSO4 and approximately twofold
higher than that observed for lead acetate,
both known transforming metals (8,16).
Furthermore, DU-UO22+ caused a dose-
dependent frequency in the transformation
ofHOS cells. To our knowledge, this is the
Table 3. Transformation potential of DU-uranyl chloride: dose response
Treatment
Control
DU-U02C12
Concentration
(pM)
0
10
25
50
100
250
Surviving
fraction
1.0
0.95
0.84
0.25
0.10
0.02
Transformation
frequency per
survivora x 104
4.2± 1.1
40.2 ± 5.0
51.1 ±7.0
108.9 ± 12.0
125.6 ± 15.0
99.4 ± 10.0
Plating efficiency Nude mice with tumorsb
in soft agar (%) (5 x 106 cells injected)
0 0/82
46 8/19
47 3/6
53 5/6
44 4/6
33 4/6
'The transformation data were analyzed similar to that in Table 1. Data are the mean ± standard error from three independent experiments
involving approximately 500 plates/treatment. The average number oftransformed foci per dish was computed from the proportion of dishes
free oftransformed colonies, f, by 1 = -In f. Transformation frequency = A/number ofsurviving cells per dish.
bTumor latency was approximately 4 weeks.
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first report ofhuman cell transformation to
the tumorigenic phenotype by any uranium
compound of any specific activity (deplet-
ed, naturally occurring, or enriched).
Although specific heavy metals and alpha
partide radiation have been shown individ-
ually to transform cultured cells and it is
not unexpected that DU could transform
cells, these results are important to the
understanding of the mechanism of the
potential carcinogenicity ofDU.
Second, these studies confirm previous
results that HOS cells can be used to assess
morphological transformation (8). Morpho-
logical transformation studies have primarily
involved rodent cell lines such as C3H and
10T1/2, and to our knowledge this is only
the second time that HOS cells have been
used for an assessment of morphological
transformation. These studies with DU
demonstrate another step in understanding
thetransformation process ofHOS cells.
The precise mechanism(s) by which
DU-UO22+ induces transformation in
HOS cells is unknown. The possibility that
alterations in specific oncogenes (e.g., ras)
and/or inactivation of tumor-suppressor
genes (e.g., p53, Rb) are involved in the
conversion of these cells to the malignant
phenotype has been considered. HOS cells
contain a mutation at codon 156 resulting
in a mutated form ofp53 protein, which is
believed to be partially responsible for their
immortalization (18). As neoplastic conver-
sion is postulated to result from a multistep
process involving cell immortalization and
gene alterations (17,19), the transforma-
tion of immortalized HOS cells by DU-
UO22+ to the malignant phenotype may
involve other cellular oncogenes in this
process. Our data demonstrate that the ras
oncogene was activated in the transforma-
tion process induced by DU exposure. The
rasoncogenes have been implicated in both
chemically and radiation-induced animal
tumors (20-22) and spontaneous human
tumors (23) and mayplay a prominent role
in the multistage conversion process.
Because others have demonstrated that
nickel-induced morphological transforma-
tion of HOS cells can affect the Rb gene
and its encoded protein (6), we examined
the status ofthis tumor-suppressor protein
in our DU-transformed clones. Changes in
the phosphorylation of the Rb tumor-sup-
pressor gene-encoded protein in the DU-
transformed dones were observed. The Rb
gene has been shown to be mutated or
inactivated in a broad spectrum ofhuman
tumors, including retinoblastoma, osteosar-
coma, lung cancer, and breast cancer, and
appears to be important in human carcino-
genesis; furthermore, the inactivation of
the Rb may be involved in the molecular
mechanism of carcinogenesis of human
osteoblasts (24). Recent in vitro studies
with nickel-transformed HOS cells suggest-
ed that nickel exposure induced a mutation
in the Rbgene that resulted in an alteration
in the function of the Rb protein (6). It
appears from our data that transformation
ofHOS cells by DU-UO22+ results from a
conversion process which also involves acti-
vation of tumor-promoting gene(s) and/or
alterations in tumor-suppressor proteins,
including ras,p53, and Rb.
Without evidence that DU-UO22+
directly affects the DNA, we can only spec-
ulate about the mechanism(s) by which
DU-UO22+ ultimately affects the ras gene
and the Rb protein. The nature of this
mechanism may involve direct damage to
the DNA and to DNA repair processes.
Transforming metals such as nickel can
induce SCEs (25) and have been shown to
directly damage DNA (26), whereas others
such as lead acetate do not directly affect
the genetic material and may induce trans-
formation via an indirect mechanism such
as changes in DNA conformation or enzy-
matic disturbances (16). An elevation in
SCE levels has also been observed as the
result of inhibition of DNA replication,
rather than by direct damage of chromo-
somes (25). Our observation ofan elevation
in the level ofSCE per cell, while consistent
with these concepts, cannot distinguish
between them. The mechanism ofaction at
the genomic level for DU-induced transfor-
mation has not been determined and awaits
further investigation; it is possible that DU
induces transformation via mechanisms
similar to those observed for nickel or lead,
orbyotherbyunknown mechanisms.
Elucidation ofthe mechanism by which
DUtransforms cells isfurthercomplicatedby
the concurrent exposure to both the chemical
(heavy metal) component and the radiologi-
cal (alpha particle) components from DU.
The chemical toxicity ofuranium, based on
animal and epidemiology studies, is well
known (27) and is believed to be responsible
for cytogenetic damage observed in the lym-
phocytes from men occupationally exposed
to insoluble uranium (28), but has not been
linked to uranium carcinogenesis. However,
our results provide evidence that the chemi-
cal/metal toxicity of DU plays a significant
role in its ability to morphologically trans-
form human cells. It is interesting to specu-
late that the observed chemical toxicity of
DU-UO22+ may be attributed to the
radiomimetic propertyofuranyl ions to actas
a transition metal to produce free radicals via
a Fenton-like reaction (29, similar to those
chemical properties generally attributed to
iron-II, copper-I, and recently demonstrated
for plutonium by Claycamp and Luo (30).
DNA is an effective chelator ofmetal ions,
whichsuggestthe possibilityofametal-medi-
ated, site-specificfreeradicaldamage (31).
Increased lung cancer risks in uranium
miners and uranium milling workers have
been attributed to exposure to thealphapar-
tide emitterradon and its daughterproducts
(1,32. In our study with DU exposures in
vitro, the biological effect from the radiolog-
ical component maybesignificantlyreduced
since so few cells (0.0014%) are actually hit
by alpha-partide emissions (1 alpha partide
traversal/cell hit). Therefore, in our study,
the defining question is whether the alpha
particle dose distribution and its track could
effectively produce a change in that target
cell that would induce or promote morpho-
logical transformation. Preliminary data
using an alpha particle microbeam have
demonstrated that one alpha particle traver-
sal of a cell is not enough to induce mor-
phological transformation (33). Although
these data from Miller's laboratory and our
results argue for a negligible role for alpha
radiation in the DU-UO22+-induced trans-
formation, low levels of exposure to alpha
radiation have been shown to induce genetic
changes (34) and chromosomal instability
(35) in the progeny ofalpha-irradiated cells.
The involvement of transmitted genetic
instability in the transformation process is
not fully understood and cannot be ignored
because it could possibly be involved in the
DU-UO22+-induced transformation.
Whether by radiation or chemical mecha-
nism, DU-UO22+ exposure is consistent
with the generally accepted features associat-
ed with neoplastic transformation ofcells by
radiation or metal exposure including for-
mation of sister chromatid exchanges
(31,36,37) and genomic instability mani-
festedas gene alterations (6,36,38).
In summary, we have used a model sys-
temofin vitrohumanosteoblastcellsexposed
for 24 hr to DU-uranyl chloride (10 FM),
nickel sulfate (10 pM), or lead acetate (10
pM) to assess relative transforming potential
ofDU in an effort to better understand the
potential health risks from long-term expo-
sure to internalized DU. Despite the well-
known low solubility ofuranyl compounds,
we found cellular uptake ofuranium consis-
tent with other transuranic compounds (39).
Asexpectedfromthepromptchemical toxici-
tyofheavymetal exposure, thelevels ofSCEs
were elevated in DU-UO22+-treated cells.
Microdosimetry studies demonstrate that few
(<1.4 x 10-3%) cells are actually hit by alpha
partides emitted from DU. This argues for a
negligible role for radiation effects from
DU-UO22+ exposure. DU-UO22+ appears to
be 1.34 (± 0.24)- and 1.91 (± 0.42)-fold
more potent that nickel sulfate and lead
acetate, respectively, in inducing an elevation
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in neoplastic cell transformation frequency in
vitro at equivalent concentrations. Hence,
2+ DU-U02+ appears to have transforming
ability slightly greater than that of many
other trace heavy metals, which also induce
neoplastic cell transformation in vitro, as well
as cause tumor formation in animals (40).
While additional animal studies are needed to
address the effect ofprotracted exposure and
tumor induction in vivo, the implication
from our model system study is that the risk
ofneoplastic induction from internalized DU
exposure may be similar to other biologically
reactive and carcinogenic heavy metal com-
pounds such as leadandnickel.
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